Akebia Therapeutics to Present Virtually at the H.C. Wainwright 24th Annual Global Investment ConferencePRNewsWire • 09/01/22
Akebia Therapeutics Inc. (AKBA) CEO John Butler on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/06/22
Akebia Therapeutics (AKBA) Surpasses Q2 Earnings and Revenue EstimatesZacks Investment Research • 08/05/22
Akebia Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business HighlightsPRNewsWire • 08/04/22
Akebia Therapeutics Announces Initial Findings from Investigator-Sponsored Clinical Study Evaluating Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Subjects with COVID-19 and Hypoxemia (VSTAT)PRNewsWire • 08/04/22
Akebia Therapeutics Regaining Rights to Vadadustat in the United States, Europe, China and Access Consortium Countries upon Termination of Collaboration and License Agreements with OtsukaPRNewsWire • 06/30/22
AKBA DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors to Secure Counsel Before Important May 13 Deadline in Securities Class Action - AKBANewsfile Corp • 05/13/22
AKBA SHAREHOLDER ALERT: Jakubowitz Law Reminds Akebia Shareholders of a Lead Plaintiff Deadline of May 13, 2022PRNewsWire • 05/13/22
AKBA LAWSUIT ALERT: Levi & Korsinsky Notifies Akebia Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlinePRNewsWire • 05/12/22
AKBA LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Akebia Therapeutics, Inc.Newsfile Corp • 05/11/22
AKBA FINAL DEADLINE FRIDAY: GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important May 13 Deadline in Securities Class Action - AKBANewsfile Corp • 05/11/22
AKBA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 13, 2022 in the Class Action Filed on Behalf of Akebia Therapeutics, Inc. Limited ShareholdersNewsfile Corp • 05/11/22
Bronstein, Gewirtz & Grossman, LLC Reminds Akebia Therapeutics, Inc. (AKBA) Shareholders of Class Action Deadline: May 13, 2022Newsfile Corp • 05/11/22